Showing Results for: “diabetes exercise”

Today, the American Diabetes Association® released the 2021 Standards of Medical Care in Diabetes. The 2021 Standards of Care is now live online in Diabetes Care . Based upon the latest scientific diabetes research and clinical trials, the Standards of Care includes new and updated recommendations and guidelines to care for people with diabetes. The Standards of Medical Care in Diabetes—2021 provides the latest in comprehensive, evidence-based recommendations for the diagnosis and treatment of children and adults with type 1, type 2, or gestational diabetes; strategies for the prevention or

Frank J. Snoek, PhD, has been selected to receive the American Diabetes Association's® (ADA's) 2019 Richard R. Rubin Award. This award recognizes a behavioral researcher who has made outstanding, innovative contributions to the study and understanding of the behavioral aspects of diabetes in diverse populations. Dr. Snoek will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7–11, 2019, at the Moscone Convention Center in San Francisco. He will deliver the Richard R. Rubin Award Lecture titled, “ #DiabetesPsychologyMatters ,” on Saturday, June 8. Currently, Dr

The American Diabetes Association® (ADA) will present the 2019 Albert Renold Award to Rudolph L. Leibel, MD. This award recognizes an individual whose career is distinguished by outstanding achievements in the training and mentorship of diabetes research scientists and in the facilitation of diabetes research. Dr. Leibel will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. Dr. Leibel is the Christopher J. Murphy Memorial Professor of Diabetes Research, Professor of Pediatrics and Medicine, Head of the

Top researchers, clinicians and educators will be recognized at the 79th Scientific Sessions for outstanding leadership and work to advance diabetes research, prevention, care and treatment The American Diabetes Association (ADA) is proud to announce the recipients of the ADA’s 2019 National Scientific and Health Care Achievement Awards. Individually and collectively, their exemplary leadership, mentorship and many achievements have advanced the field of diabetes care and improved health outcomes for people living with diabetes. “This year’s National Scientific and Health Care Achievement

Last week, at its first-ever Cost of Care Summit, the American Diabetes Association ® (ADA) shared the results of a new study on Health Equity and Diabetes Technology: A Study of Access to Continuous Glucose Monitors by Payer and Race . The study, featuring analysis by Health Management Associates, finds that although access to CGMs provides potentially life-changing benefits for diabetes management, poorer, older, and Black Americans have less access to these devices than others. “It is disappointing to see that, today, access to vital diabetes management technology like CGMs is uneven and

Update on SCORED and SOLOIST trials shows reduction in cardiovascular events and stroke using glucose-lowering agents Results from two large clinical trials show significant and early benefits from sotagliflozin, a drug that inhibits sodium-glucose transport protein 2 (SGLT2) and sodium-glucose transport protein 1 (SGLT1) in reducing heart failure, heart attack, and stroke—major problems in people with diabetes. The findings were presented at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Patients with diabetes are at an increased risk of life-threatening

Leading diabetes researchers and clinicians from around the world highlight impact of health disparities on diabetes care The American Diabetes Association® (ADA) is highlighting the latest understanding of how to address health disparities laid bare by the pandemic at the virtual 81st Scientific Sessions. Taking place June 25–29, the ADA’s Scientific Sessions is the world’s largest scientific meeting focused on diabetes research, prevention, and care. These expert discussions come at a time when 76% of Americans currently living in poverty are people of color. Diabetes prevalence is inversely

Consensus report outlines the positive impact of diabetes self-management education and support and the critical need for increased access Seven leading diabetes organizations issued a consensus report today highlighting the value of diabetes self-management education and support (DSMES) services as part of comprehensive diabetes medical care. The report provides compelling evidence for the need for increased utilization of DSMES, four key times that DSMES is most beneficial, and specific recommendations for both clinicians and health systems to increase access to and participation in DSMES

Tracey D. Brown, Chief Executive Officer of the American Diabetes Association (ADA), issued the following statement in response to the unprecedented number of Members of Congress who invited people living with diabetes to join them at President Donald J. Trump’s State of the Union address: “Tonight, at least 13 Members of Congress will host their constituents that are living with diabetes, and who represent the seven million Americans dependent on insulin, at the State of the Union address. They will elevate the voices of all people with diabetes and their families, many of whom struggle to

Results of the PIONEER 6 trial indicate oral semaglutide is safe for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk, according to results announced at the symposium titled “Oral Semaglutide—The PIONEER Program Trials” today at the American Diabetes Association’s® (ADA) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. Oral semaglutide reduced cardiovascular death and all-cause mortality by nearly 50 percent, based on median follow up of 15.9 months. PIONEER 6 was conducted across 21 countries and included 3,183 participants who were randomized